Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany women notice changes to their periods on Wegovy. Cycles can become irregular, heavier, or more noticeable in the early weeks of treatment — and semaglutide is not the only reason. Rapid weight loss itself alters the hormonal signals that govern menstruation, so the two effects can be hard to untangle. These are prescription-only medicines, and any cycle changes worth noting are exactly the kind of thing a prescriber should hear about.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The connection between body weight and periods is well-established. Fat tissue is hormonally active: it produces and stores oestrogen, and it influences the signals the brain sends to the ovaries. When weight falls quickly (which it can do in the early months of Wegovy treatment) oestrogen levels can drop sharply, and the hypothalamic-pituitary-ovarian axis (the hormonal chain that drives your cycle) can temporarily lose its usual rhythm.
Semaglutide, the active ingredient in Wegovy, reduces appetite and slows gastric emptying. For women with higher starting weights, particularly those with polycystic ovary syndrome (PCOS), the effect can actually restore ovulation where it had been suppressed before. That is not a benefit to overlook, but it does mean fertility may increase, sometimes unexpectedly, as weight falls. The semaglutide overview on our site covers the broader hormonal picture.
The upshot is that cycle changes on Wegovy are rarely caused by semaglutide alone. They tend to reflect the body's hormonal response to weight loss at speed. Whether that means a missed period, a heavier one, or the return of a cycle that had been absent for years depends heavily on where you are starting from.
Both are reported, and neither is unusual. Some women (particularly at higher starting BMIs or with PCOS) find that periods which had been absent or infrequent for years return as weight falls. The hormonal environment shifts enough for ovulation to restart. For detailed reading on this, the page on whether Wegovy can cause periods to return goes further into that mechanism.
On the other side, some women experience temporary cycle disruption or missed periods, especially in the early months of treatment. Rapid calorie restriction (which Wegovy's appetite suppression can effectively create) is a known trigger for hypothalamic amenorrhoea, where the brain pauses reproductive signalling in response to energy deficit. This tends to be temporary, but it should not be ignored.
There is currently no large-scale clinical trial data specifically examining menstrual outcomes in the Wegovy STEP programme; the trials were not designed to track this. What we have are patterns emerging from clinical practice and patient reporting, which is why the NHS patient information for semaglutide advises discussing any new or changing symptoms with your healthcare team. If you are wondering whether your periods stopping on semaglutide is connected to treatment, the page on semaglutide and stopped periods addresses that directly.
Yes, and this is worth paying close attention to. If Wegovy is restoring ovulation in women who had previously not been ovulating, the risk of pregnancy rises even if contraception felt unnecessary before. The NHS advises using effective contraception throughout treatment and for a period after stopping, your prescriber or GP can advise on the right method for you.
There is also a practical note specific to the injection: the NHS England guidance on weight management medicines recommends considering transdermal forms of HRT (patches or gels) rather than oral HRT while on tirzepatide, for absorption reasons, but for semaglutide, current evidence does not suggest the same concern about oral contraceptive pill absorption. Wegovy is an injection, not a tablet taken by mouth, so it does not interact with oral contraceptive absorption in the way that oral medicines can. Still, a conversation with your GP or prescriber about your specific contraceptive choice is sensible, especially if your cycles have changed and you are not planning a pregnancy.
It is also worth knowing that Wegovy is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. These are clinical decisions, not ones to navigate alone. The full picture of how Wegovy works and what to expect from treatment is on the Wegovy treatment page.
Mild irregularity in the first couple of months (a slightly different cycle length, a heavier-than-usual bleed, or a period arriving a week late) is common during rapid weight loss and does not always require urgent attention. That said, there are patterns that warrant a prompt call to your prescriber or GP.
Seek advice if: periods stop entirely for three months or more; bleeding becomes unusually heavy or prolonged; you experience pain that is new or worsening; you think you might be pregnant; or you feel unwell alongside the change. The page on how Wegovy affects periods lists these signs in more detail. For anything that feels acute or alarming, contact your GP or call 111, do not wait for a routine review.
At nume, our prescribers hear about cycle changes regularly and take them seriously. Every repeat prescription involves a clinical review, your prescriber looks at how treatment is going, not just whether weight loss is on track. If you keep your Wegovy pen in your bag or your gym kit alongside a daily reminder in your phone, it also helps to note any cycle changes in the same place, so you have a clear picture to share. Our clinical team is available for aftercare queries seven days a week. For a broader look at private treatment options, the weight-loss treatments overview is a good starting point, and Wegovy pricing information explains what a private prescription includes. When you are ready to talk through your circumstances, you can check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.